CEA [CHINA EASTERN AIRLINES] 6-K: (Original Filing)
[]
LITB [LightInTheBox] 6-K: (Original Filing)
[LightInTheBox Holding Co., Ltd. Responds to Class Action Lawsuit The Company has reviewed the claims asserted in the complaint and believes that they are without merit. While the Company has not yet been served with a copy of the complaint, it intends to work with Simpson Thacher & Bartlett LLP, its legal counsel, to vigorously defend itself in this matter.]
LITB [LightInTheBox] 6-K: LightInTheBox Holding Co., Ltd. Responds to Class Action
[LightInTheBox Holding Co., Ltd. Responds to Class Action Lawsuit The Company has reviewed the claims asserted in the complaint and believes that they are without merit. While the Company has not yet been served with a copy of the complaint, it intends to work with Simpson Thacher & Bartlett LLP, its legal counsel, to vigorously defend itself in this matter.]
BSPM [Biostar Pharmaceuticals,] S-8: (Original Filing)
[FORM S-8 SECURITIES ACT OF 1933 REGISTRATION STATEMENT UNDER THE Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 including zip code) (Full title of the plan) Ronghua Wang, President and Chief Executive Officer No. 588 Shiji Xi Avenue,] [Biostar Pharmaceuticals, Inc. 2012 Stock Option Compensation Plan This Biostar Pharmaceuticals, Inc. 2012 Stock Option Compensation Plan Plan 1. Definitions. (a) Board " (b) Code " (c) Committee Rule 16b-3 Exchange Act " (d) Company " (e) Exchange Act " (f) Fair Market Value " (g) Grant " (h) Grant Agreement " (i) Maryland Securities Rules " (j) Option Optionee] [[Schiff Hardin letterhead] August 28, 2013 Biostar Pharmaceuticals, Inc. No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China Ladies and Gentlemen: Schiff Hardin LLP EX-5.1 3 ex5-1.htm] [Consent of Independent Registered Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 dated August 28, 2013 of Biostar Pharmaceuticals, Inc. of our report dated April 11, 2013 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Certified Public Accountants Hong Kong August 28, 2013 EX-23.2 5 ex23-2.htm]
BSPM [Biostar Pharmaceuticals,] S-8: FORM S-8 SECURITIES ACT OF 1933 REGISTRATION STATEMENT
[FORM S-8 SECURITIES ACT OF 1933 REGISTRATION STATEMENT UNDER THE Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 including zip code) (Full title of the plan) Ronghua Wang, President and Chief Executive Officer No. 588 Shiji Xi Avenue,] [Biostar Pharmaceuticals, Inc. 2012 Stock Option Compensation Plan This Biostar Pharmaceuticals, Inc. 2012 Stock Option Compensation Plan Plan 1. Definitions. (a) Board " (b) Code " (c) Committee Rule 16b-3 Exchange Act " (d) Company " (e) Exchange Act " (f) Fair Market Value " (g) Grant " (h) Grant Agreement " (i) Maryland Securities Rules " (j) Option Optionee] [[Schiff Hardin letterhead] August 28, 2013 Biostar Pharmaceuticals, Inc. No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China Ladies and Gentlemen: Schiff Hardin LLP EX-5.1 3 ex5-1.htm] [Consent of Independent Registered Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 dated August 28, 2013 of Biostar Pharmaceuticals, Inc. of our report dated April 11, 2013 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Certified Public Accountants Hong Kong August 28, 2013 EX-23.2 5 ex23-2.htm]
CREG [CHINA RECYCLING ENERGY] SC 13D/A: SHARE PURCHASE AGREEMENT Agreement Agreement Date Purchaser CAGP
[SHARE PURCHASE AGREEMENT Agreement Agreement Date Purchaser CAGP CAGP Co-Invest Sellers Seller This SHARE PURCHASE AGREEMENT (the Party Parties Each of the Purchaser and the Sellers is hereinafter referred to individually as a RECITALS WHEREAS Shares Company WHEREAS WHEREAS NOW, THEREFORE ARTICLE I Purchase and Sale of Shares Section 1.01 Sale and Purchase Schedule 1 Purchase Price Section] [Explanatory Note ITEM 2. Identity and Background Item 2 of the Statement is amended and restated in its entirety by inserting the following information: This statement is being filed by the following persons, (each is hereinafter individually referred to as a Reporting Person and collectively as the Reporting Persons.): Carlyle Group Management L.L.C. The Carlyle Group, L.P. Carlyle Holdings II]
ISS [iSoftStone] 6-K: (Original Filing)
[iSoftStone Holdings Limited Form 6-K Page 3 4]
ISS [iSoftStone] 6-K: iSoftStone Holdings Limited Form 6-K Page 3 4
[iSoftStone Holdings Limited Form 6-K Page 3 4]
DL [China Distance Education] 6-K: (Original Filing)
[Form 6-K TABLE OF CONTENTS Page 3 4]
DL [China Distance Education] 6-K: Form 6-K TABLE OF CONTENTS Page 3 4
[Form 6-K TABLE OF CONTENTS Page 3 4]
